Royal Philips: Late-breaking data at ACC.22 with over 1 million patients demonstrates a major gap in guideline adherence resulting in higher mortality for patients with infected CIEDs

April 4, 2022 Largest ever real-world analysis of Cardiac Implantable Electronic Device (CIED) infection treatment presented at the American College of Cardiology's 71st Annual Scientific Session

Related Keywords

United States ,Netherlands ,Washington ,Amsterdam ,Noord Holland ,American ,Coll Cardiol ,Philipsby Sean Pokorney ,Jonathanp Piccini ,Clin Electrophysiol ,Chris Landon ,Founder Of Arrhythmia Alliance ,European Heart Rhythm Association ,American Heart Association ,American College Of Cardiology ,Duke Clinical Research Institute ,Philips ,Duke Heart Center ,Philips Global Press Office ,Duke University ,Cardiac Implantable Electronic Device ,American College ,Annual Scientific Session ,Medicare Study ,Lead Management ,Assistant Professor ,Duke University School ,Duke Clinical Research ,Cardiac Electrophysiology ,Duke Heart ,Trudie Lobban ,Arrhythmia Alliance ,Senior Vice President ,General Manager Image Guided Therapy Devices ,Late Breaking Clinical ,United States April ,Consensus Statement ,Heart Rhythm ,Internal Medicine ,Contemporary Setting ,Multicenter Observational Retrospectivestudy ,Consecutive Laser Lead Extractions ,Royal ,Gate ,Breaking ,Data ,Dover ,Billion ,Patients ,Emonstrates ,Major ,Guideline ,Adherence ,Resulting ,Higher ,Ortality ,Infected ,Ieds ,